Dimension of model parameter space and operating characteristics in adaptive dose-finding studies
From MaRDI portal
Cites work
- A simple technique to evaluate model sensitivity in the continual reassessment method
- A weakly informative default prior distribution for logistic and other regression models
- Approximation Theorems of Mathematical Statistics
- Coherence principles in dose-finding studies
- Consistency of continual reassessment method under model misspecification
- Continual reassessment method for partial ordering
- Continual Reassessment Method: A Likelihood Approach
- Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
- Dose-Finding Based on Efficacy-Toxicity Trade-Offs
- Dose-finding designs for HIV studies
- scientific article; zbMATH DE number 3746271 (Why is no real title available?)
- Non-parametric optimal design in dose finding studies
- The treatment versus experimentation dilemma in dose finding studies
- TWO-SAMPLE CONTINUAL REASSESSMENT METHOD
- Unifying CRM and EWOC designs for phase I cancer clinical trials
Cited in
(4)- A Bayesian dose-finding design incorporating toxicity data from multiple treatment cycles
- On inclusion of covariates in model based dose finding clinical trial designs
- Phase I/II design for selecting subgroup-specific optimal biological doses for prespecified subgroups
- BAR12: Bayesian autoregressive phase 1-2 design for cell therapy trials with manufacturing changes
This page was built for publication: Dimension of model parameter space and operating characteristics in adaptive dose-finding studies
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6949199)
